The pH-triggered polyglutamate brush co-delivery of MDR1 and survivin-targeting siRNAs efficiently overcomes multi-drug resistance of NSCLC
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The pH-triggered polyglutamate brush co-delivery of MDR1 and survivin-targeting siRNAs efficiently overcomes multi-drug resistance of NSCLC
Authors
Keywords
-
Journal
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
Volume -, Issue -, Pages 1-11
Publisher
Informa UK Limited
Online
2020-09-14
DOI
10.1080/03639045.2020.1822860
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Response of pH-Sensitive Doxorubicin Nanoparticles on Complex Tumor Microenvironments by Tailoring Multiple Physicochemical Properties
- (2020) Huajian Chen et al. ACS Applied Materials & Interfaces
- The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells
- (2020) Yung-Chieh Chang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting Epidermal Growth Factor Receptor in Non-Small-Cell-Lung Cancer: Current State and Future Perspective
- (2019) Shui-ming Bao et al. Anti-Cancer Agents in Medicinal Chemistry
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
- (2019) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells
- (2016) Aparajitha Vaidyanathan et al. BRITISH JOURNAL OF CANCER
- Survivin: a unique target for tumor therapy
- (2016) Himani Garg et al. Cancer Cell International
- Highly stable polyglutamate derivatives/siRNA polyplex efficiently down-relegate survivin expression and augment the efficacy of cisplatin
- (2016) Zhongjuan Wang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Quality of life in lung cancer patients due to treatment
- (2016) Branka Milošević et al. Signa Vitae
- Enhanced Therapeutic siRNA to Tumor Cells by a pH-Sensitive Agmatine–Chitosan Bioconjugate
- (2015) Yongmao Li et al. ACS Applied Materials & Interfaces
- Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
- (2015) Khalid O Alfarouk et al. Cancer Cell International
- pH-responsive zwitterionic copolypeptides as charge conversional shielding system for gene carriers
- (2013) Huayu Tian et al. JOURNAL OF CONTROLLED RELEASE
- Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
- (2011) Ana-Maria Florea et al. Cancers
- Reversal of multidrug resistance by reduction-sensitive linear cationic click polymer/iMDR1-pDNA complex nanoparticles
- (2010) Yu Gao et al. BIOMATERIALS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started